1 not yet recruiting, 1 recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Adjunct in the Treatment of Depressive Disorder: new trials by email Literature Review of Adjunct in the Treatment of Depressive Disorder trials Research Report on Adjunct in the Treatment of Depressive Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Open-Label, 52-Week Extension Study to Evaluate the Maintenance of Remission, Relapse Prevention, and Long-Term Safety of CreNeuroS™ in Patients With Major Depressive Disorder Who Achieved Remission Following an 8-Week Parent Study No intervention, CreNeuroS™ CNS Fish Oil Plus Softgels, 1 capsule orally once daily, CreNeuroS™ CNS Fish Oil Plus Softgels, 2 capsule orally once daily - Adjunct in the Treatment of Depressive Disorder | Not applicable | Recruiting | Sichuan Credit Pharmaceutical Co., Ltd. | 60 | 2026-09-11 | 2026-10-23 |
| Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram. 1. Escitalopram (as escitalopram oxalate) tablet 2. CreNeuroSTM CNS Fish Oil Plus Softgels, 1. Escitalopram (as escitalopram oxalate) tablet 2. Placebo softgels - Adjunct in the Treatment of Depressive Disorder | Not applicable | Not yet recruiting | Sichuan Credit Pharmaceutical Co., Ltd. | 80 | 2026-06-11 | 2026-06-16 |
Escitalopram (1) · Tablets (1)
Sichuan Credit Pharmaceutical Co., Ltd. (2)
India (2)